Cite
HARVARD Citation
Rathe, M. et al. (2020). Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia. Apmis. 128 (5), pp. 414-419. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rathe, M. et al. (2020). Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia. Apmis. 128 (5), pp. 414-419. [Online].